These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

211 related articles for article (PubMed ID: 11759540)

  • 1. ["Academic detailing"].
    Chabot JM
    Rev Prat; 2001 Oct; 51(15):1687-8. PubMed ID: 11759540
    [No Abstract]   [Full Text] [Related]  

  • 2. Prescribing practices.
    Lexchin J
    CMAJ; 1994 Jul; 151(2):140. PubMed ID: 8039058
    [No Abstract]   [Full Text] [Related]  

  • 3. Marketing drugs: debating the real cost. Concern about close ties between doctors and pharmaceutical firms are prompting new financial disclosure laws and education efforts.
    Brand R
    State Legis; 2008 Sep; 34(8):26-9. PubMed ID: 18754159
    [No Abstract]   [Full Text] [Related]  

  • 4. A gap in the market.
    Lancet Neurol; 2005 Sep; 4(9):517. PubMed ID: 16109355
    [No Abstract]   [Full Text] [Related]  

  • 5. Educating ourselves.
    Potdar RD
    Indian Pediatr; 2000 Nov; 37(11):1287-8. PubMed ID: 11086325
    [No Abstract]   [Full Text] [Related]  

  • 6. Academic detailing.
    Nemec PB
    Psychiatr Rehabil J; 2011; 34(3):257-9. PubMed ID: 21208867
    [No Abstract]   [Full Text] [Related]  

  • 7. Academic drug detailing: an evidence-based alternative.
    Kondro W
    CMAJ; 2007 Feb; 176(4):429-31. PubMed ID: 17296946
    [No Abstract]   [Full Text] [Related]  

  • 8. Medicine that's a little too personalized.
    Gilbert S
    Hastings Cent Rep; 2011; 41(4):Inside back cover. PubMed ID: 21845924
    [No Abstract]   [Full Text] [Related]  

  • 9. A philosophy for marketing independent practice.
    Koetting RA
    J Am Optom Assoc; 1988 Jan; 59(1):58-61. PubMed ID: 3343484
    [No Abstract]   [Full Text] [Related]  

  • 10. Identifying early prescribers of cycloxygenase-2 inhibitors (COX-2s) in Nova Scotia, Canada: Considerations for targeted academic detailing.
    Groves KE; Schellinck T; Sketris I; MacKinnon NJ
    Res Social Adm Pharm; 2010 Sep; 6(3):257-67. PubMed ID: 20813338
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Stretching the managed care dollar in the new millennium: the practice of detailing primary care physicians.
    Hill CD; Bunn DN; Hawkins JR
    Manag Care Q; 2002; 10(2):18-23. PubMed ID: 12148477
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Learning how drug companies promote medicines in Nepal.
    Giri BR; Shankar PR
    PLoS Med; 2005 Aug; 2(8):e256. PubMed ID: 16120011
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Why aren't we using beta blockers after acute MI?
    Weichel AS
    Am Fam Physician; 2000 Oct; 62(8):1771-2. PubMed ID: 11057834
    [No Abstract]   [Full Text] [Related]  

  • 14. The role of industry in brand or generic drug recognition.
    Stephens MB; Maslach A; Childress M
    Fam Med; 2009 Feb; 41(2):82-3. PubMed ID: 19184678
    [No Abstract]   [Full Text] [Related]  

  • 15. Drug advertisements: what a physician should know.
    Ghosh RK; Ghosh SM
    N Z Med J; 2010 May; 123(1314):154-6. PubMed ID: 20581923
    [No Abstract]   [Full Text] [Related]  

  • 16. How direct-to-consumer television advertising for osteoarthritis drugs affects physicians' prescribing behavior.
    Bradford WD; Kleit AN; Nietert PJ; Steyer T; McIlwain T; Ornstein S
    Health Aff (Millwood); 2006; 25(5):1371-7. PubMed ID: 16966735
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Consequences of direct-to-consumer advertising of prescription drugs.
    Lexchin J
    Can Fam Physician; 1997 Apr; 43():594-6, 602-5. PubMed ID: 9111973
    [No Abstract]   [Full Text] [Related]  

  • 18. A clustered randomized trial of the effects of feedback using academic detailing compared to postal bulletin on prescribing of preventative cardiovascular therapy.
    Naughton C; Feely J; Bennett K
    Fam Pract; 2007 Oct; 24(5):475-80. PubMed ID: 17670803
    [TBL] [Abstract][Full Text] [Related]  

  • 19. 'A pill for every ill': explaining the expansion in medicine use.
    Busfield J
    Soc Sci Med; 2010 Mar; 70(6):934-41. PubMed ID: 20096496
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Effect of an academic detailing intervention on the utilization rate of cyclooxygenase-2 inhibitors in the elderly.
    Graham SD; Hartzema AG; Sketris IS; Winterstein AG
    Ann Pharmacother; 2008 Jun; 42(6):749-56. PubMed ID: 18430793
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 11.